Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 10/20 | 0.54 |
| ▸ | CYP11B1 | P15538 | 10/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 9/20 | 0.54 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9664994 | 0.85 | CYP19A1 (0.52) | CYP19A1CYP11B1CYP11B2TBXAS1ADRA2C | |
| Water SCHEMBL9193221 | 0.84 | CYP19A1 (0.51) | CYP19A1CYP11B1CYP11B2TBXAS1CYP2A6 | |
| SCHEMBL9662930 | 0.81 | CYP19A1 (0.54) | CYP19A1CYP11B1CYP11B2TBXAS1ADRA2C | |
| SCHEMBL9662907 | 0.78 | CCNT1 (0.46) | CYP19A1CYP11B1CYP11B2TBXAS1ADRA2C | |
| SCHEMBL9665025 | 0.77 | CYP19A1 (0.45) | CYP19A1CYP11B1CYP11B2TBXAS1ADRA2C | |
| SCHEMBL9707231 | 0.77 | CYP11B1 (0.51) | CYP19A1CYP11B1CYP11B2TBXAS1CYP2A6 | |
| Hydrochloric Acid SCHEMBL9662260 | 0.76 | CYP19A1 (0.51) | CYP19A1CYP11B1CYP11B2TBXAS1ADRA2C | |
| SCHEMBL9662263 | 0.75 | CYP19A1 (0.51) | CYP19A1CYP11B1CYP11B2TBXAS1CYP2A6 | |
| SCHEMBL9663633 | 0.75 | CYP19A1 (0.54) | CYP19A1CYP11B1CYP11B2TBXAS1CYP2A6 | |
| SCHEMBL13073711 | 0.75 | KDM4E (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0260744-B1 | (1H-IMIDAZOL-1-YLMETHYL) SUBSTITUTED BENZIMIDAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-12-16 | — | — | EP | disclosed |
| US-4859684-A | (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-08-22 | — | — | US | disclosed |
| EP-0260744-A2 | (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1988-03-23 | — | — | EP | disclosed |